Skip to content

Fetal Programming of Obesity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01131117
Enrollment
320
Registered
2010-05-26
Start date
2010-04-02
Completion date
2024-11-30
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Pregnancy

Keywords

healthy, women, pregnancy

Brief summary

The overall goal of this project is to understand how a mother's health at conception may influence her child's growth and development.

Detailed description

The purpose of this study is to determine how the mother's health prior to or at the beginning of pregnancy may influence her child's growth and development. We plan to: 1) longitudinally and simultaneously assess a true measure of body composition (lean and fat mass) of the offspring, assess body composition of both parents, and obtain dietary intake data of the mother and offspring; 2) determine endocrine and metabolic profiles of the mother at baseline (pre-conception), during pregnancy and at birth (such as insulin, glucose, leptin); 3) determine the energy expenditure and physical activity of the mother and the child; 4) determine gene expression of the placenta and umbilical cord via gene microarray and real time PCR; and 5) focused on appropriate-for-gestational age (AGA) infants (the majority of infants born from normal and overweight mothers).Accordingly, this study will provide much needed comprehensive information on the possible effect of fetal programming on the development of pediatric obesity.

Interventions

None listed

Sponsors

Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy * 21 years of age or older * second pregnancy, singleton * conceived without fertility treatments

Exclusion criteria

* Preexisting medical conditions * Sexually transmitted diseases * Medical complications during pregnancy * Medications during pregnancy known to influence fetal growth * Smoking, alcohol drinking * Excessive physical activity level which could affect the outcome of interest.

Design outcomes

Primary

MeasureTime frameDescription
Child body composition24 monthslean and fat mass of the child

Secondary

MeasureTime frameDescription
Placenta protein content9 monthsvia gene microarray and real time PCR
Child metabolism24 monthsmonitor with a metabolic cart
Child development24 monthsMonitored from 2wks up to 24 months
Child dietary intake24 monthsFood records for each visit will be obtained
Placenta gene expression9 monthsvia gene microarray and real time PCR

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026